Patents by Inventor Patricia Culp

Patricia Culp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210395361
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind a Siglec-5 protein, e.g., human Siglec-5, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: July 26, 2019
    Publication date: December 23, 2021
    Applicant: Alector LLC
    Inventors: Patricia CULP, Rashmi BANKOTI, Helen LAM, Arnon ROSENTHAL
  • Publication number: 20210317208
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a CD33 polypeptide, e.g., a mammalian CD33 or human CD33, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: August 30, 2019
    Publication date: October 14, 2021
    Applicant: Alector LLC
    Inventors: Patricia CULP, Helen LAM, Wei-Hsien HO, Leonard G. PRESTA, Arnon ROSENTHAL
  • Publication number: 20210277113
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRP?1 polypeptide, e.g., a human SIRP?1, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: June 28, 2019
    Publication date: September 9, 2021
    Applicant: Alector LLC
    Inventors: Andrew Pincetic, Patricia Culp, Arnon Rosenthal
  • Publication number: 20210246204
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Siglec-7 protein, e.g., human Siglec-7 or a mammalian Siglec-7, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: June 7, 2019
    Publication date: August 12, 2021
    Applicant: Alector LLC
    Inventors: Patricia CULP, Seung-Joo LEE, Helen LAM, Wei-Hsien HO, Arnon ROSENTHAL
  • Publication number: 20210139581
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: May 7, 2020
    Publication date: May 13, 2021
    Applicant: ALECTOR LLC
    Inventors: Patricia CULP, Helen LAM, Arnon ROSENTHAL, Seung-Joo LEE, Nels P. NIELSON, Robert PEJCHAL
  • Publication number: 20210017275
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind on or more epitopes within a Siglec-5 protein, e.g., human Siglec-5 or a mammalian Siglec-5, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: May 15, 2018
    Publication date: January 21, 2021
    Applicant: Alector LLC
    Inventors: Kate MONROE, Helen LAM, Patricia CULP, Arnon ROSENTHAL
  • Patent number: 10711062
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: July 14, 2020
    Assignee: ALECTOR LLC
    Inventors: Patricia Culp, Helen Lam, Arnon Rosenthal, Seung-Joo Lee, Nels P. Nielson, Robert Pejchal
  • Publication number: 20190359707
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, antibodies, antibody fragments, etc., that specifically bind a SIRPA polypeptide, e.g., a mammalian SIRPA or human SIRPA, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: May 24, 2019
    Publication date: November 28, 2019
    Applicant: Alector LLC
    Inventors: Andrew Pincetic, Wei-Hsien Ho, Patricia Culp, Arnon Rosenthal
  • Patent number: 10233258
    Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: March 19, 2019
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Yoshiko Akamatsu, Patricia Culp, Charles M. Forsyth, Ping Y. Huang, David Powers, Alan F. Wahl, Shiming Ye
  • Publication number: 20190040131
    Abstract: The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
    Type: Application
    Filed: August 3, 2018
    Publication date: February 7, 2019
    Applicant: ALECTOR LLC
    Inventors: Patricia Culp, Helen Lam, Arnon Rosenthal, Seung-Joo Lee, Nels P. Nielson, Robert Pejchal
  • Publication number: 20180194862
    Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.
    Type: Application
    Filed: February 23, 2018
    Publication date: July 12, 2018
    Inventors: Yoshiko AKAMATSU, Patricia CULP, Charles M. FORSYTH, Ping Y. HUANG, David POWERS, Alan F. WAHL, Shiming YE
  • Publication number: 20170342169
    Abstract: The present disclosure provides bispecific proteins that bind to two antigens, as well as their compositions, uses, and methods of making.
    Type: Application
    Filed: May 26, 2017
    Publication date: November 30, 2017
    Inventors: Yoshiko AKAMATSU, Patricia Culp, Charles M. Forsyth, Ping Y. Huang, David Powers, Alan F. Wahl, Shiming Ye
  • Patent number: 9056908
    Abstract: Provided herein are compositions comprising monoclonal antibodies and antigen binding fragments thereof that bind TweakR and methods for their use in treating cancer.
    Type: Grant
    Filed: August 4, 2008
    Date of Patent: June 16, 2015
    Assignee: AbbVie Biotherapeutics Inc.
    Inventor: Patricia Culp
  • Publication number: 20100074841
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Application
    Filed: November 19, 2009
    Publication date: March 25, 2010
    Applicant: FACET BIOTECH CORPORATION
    Inventors: Debbie Law, Kurt C. Gish, Richard Murray, Patricia Culp
  • Publication number: 20090074762
    Abstract: Compositions and methods for treating solid tumors are provided herein.
    Type: Application
    Filed: August 4, 2008
    Publication date: March 19, 2009
    Applicant: PDL BIOPHARMA, INC.
    Inventor: Patricia Culp
  • Publication number: 20080175839
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 24, 2008
    Applicant: Protein Design Labs, Inc.
    Inventors: Debbie Law, Kurt C. Gish, Richard Murray, Patricia Culp
  • Publication number: 20080171039
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 17, 2008
    Applicant: Protein Design Labs, Inc.
    Inventors: Debbie Law, Kurt C. Gish, Richard Murray, Patricia Culp
  • Publication number: 20040141983
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Application
    Filed: January 29, 2004
    Publication date: July 22, 2004
    Applicant: Protein Design Labs, Inc.
    Inventors: Debbie Law, Kurt C. Gish, Richard Murray, Patricia Culp